Could fat stem cells fight Alzheimer's? new trial tests repeat brain injections
NCT ID NCT07373067
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests whether repeated injections of a patient's own fat-derived stem cells into the brain are safe for people with mild to moderate Alzheimer's. Nine participants who previously received a single dose will now get up to six injections every two months. Researchers will monitor side effects and check for changes in brain proteins linked to Alzheimer's.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- autologous adipose-derived stem cells (RB-ADSC)
- What this could lead to
- If safe and effective, this approach could slow Alzheimer's progression by reducing harmful tau proteins in the brain.
- What could go wrong
- This is a very early, small trial (9 people) focused on safety, not proof of benefit. Stem cell injections into the brain carry risks like infection or inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple questionnaire empower dementia caregivers after hospital stays?
- Could your heart hold the key to Alzheimer's prevention?
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Can a Voice-Based app map healthy brain aging across 80 years?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can brain scans and gut bacteria reveal Alzheimer's secrets?